SCHEMBL25533732

SCHEMBL25533732

CC1(C)c2ccccc2-c2ccc(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccc6c(c5)C(c5ccccc5)(c5ccccc5)c5ccccc5-6)n4)c4ccccc34)cc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.34
MEN1 O00255 9/20 0.33
KMT2A Q03164 9/20 0.33
MAPT P10636 7/20 0.33
ALDH1A1 P00352 5/20 0.33
HPGD P15428 5/20 0.33
ACACA Q13085 2/20 0.33
NTSR1 P30989 1/20 0.33
KDM4E B2RXH2 5/20 0.33
LMNA P02545 3/20 0.33
AGTR1 P30556 3/20 0.33
GLA P06280 1/20 0.33
PDK2 Q15119 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
OPRK1 P41145 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32
CHRNB2 P17787 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25534918 1.00 TDP1 (0.34) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL25535214 0.96 MEN1 (0.35) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL25534022 0.96 MEN1 (0.35) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL25538838 0.94 CYP1A1 (0.34) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL25534929 0.93 MEN1 (0.38) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL25539373 0.93 CYP1A1 (0.32) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25533508 0.92 MEN1 (0.35) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL25534655 0.92 MEN1 (0.35) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL25534877 0.92 MEN1 (0.39) TDP1MEN1KMT2AMAPTALDH1A1
SCHEMBL25533729 0.92 MEN1 (0.39) TDP1MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM TDP1 2240/4885MEN1 267/4885KMT2A 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.